Company / R&D per Share
Ensysce Biosciences, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.32
FY2025
5-year range
$5.32 / $37.11
FY2022-FY2025
Trend
-85.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $37.11 to $5.32 over the past 2 years.
Based on SEC 10-K filings.
5.32 in FY2025 with a 3-year CAGR of -29.3%.
Declined from $37.11 to $5.32 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -29.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 85.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.32 | -85.3% |
| FY2024 | $36.18 | -2.5% |
| FY2023 | $37.11 | +146.1% |
| FY2022 | $15.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026